62 related articles for article (PubMed ID: 38612711)
1. Sterile, abscess-like cerebral lesion during trastuzumab therapy after HER2 status switch in a triple negative breast cancer patient: a case report and literature review.
Mezei T; Hajdu M; Czigléczki G; Lotz G; Kocsis J; Kulka J; Horváth A
BMC Cancer; 2020 Jul; 20(1):615. PubMed ID: 32611325
[TBL] [Abstract][Full Text] [Related]
2. Advances in the systemic treatment of triple-negative breast cancer.
Lebert JM; Lester R; Powell E; Seal M; McCarthy J
Curr Oncol; 2018 Jun; 25(Suppl 1):S142-S150. PubMed ID: 29910657
[TBL] [Abstract][Full Text] [Related]
3. PFDN4 as a Prognostic Marker Was Associated with Chemotherapy Resistance through CREBP1/AURKA Pathway in Triple-Negative Breast Cancer.
Wang SH; Yeh CH; Wu CW; Hsu CY; Tsai EM; Hung CM; Wang YW; Hsieh TH
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612711
[TBL] [Abstract][Full Text] [Related]
4. Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple-negative breast cancer.
Yang N; Wang C; Wang J; Wang Z; Huang D; Yan M; Kamran M; Liu Q; Xu B
J Cell Mol Med; 2019 Sep; 23(9):6442-6453. PubMed ID: 31359594
[TBL] [Abstract][Full Text] [Related]
5. The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors.
Tormo E; Ballester S; Adam-Artigues A; Burgués O; Alonso E; Bermejo B; Menéndez S; Zazo S; Madoz-Gúrpide J; Rovira A; Albanell J; Rojo F; Lluch A; Eroles P
Sci Rep; 2019 Mar; 9(1):5316. PubMed ID: 30926829
[TBL] [Abstract][Full Text] [Related]
6. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Loibl S; O'Shaughnessy J; Untch M; Sikov WM; Rugo HS; McKee MD; Huober J; Golshan M; von Minckwitz G; Maag D; Sullivan D; Wolmark N; McIntyre K; Ponce Lorenzo JJ; Metzger Filho O; Rastogi P; Symmans WF; Liu X; Geyer CE
Lancet Oncol; 2018 Apr; 19(4):497-509. PubMed ID: 29501363
[TBL] [Abstract][Full Text] [Related]
7. CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231.
Yang M; Li Y; Ruan Y; Lu Y; Lin D; Xie Y; Dong B; Dang Q; Quan C
Mol Cell Biochem; 2018 Jun; 443(1-2):169-180. PubMed ID: 29159771
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Aurora kinase A triggers programmed death-ligand 1-mediated immune suppression by activating MYC transcription in triple-negative breast cancer.
Sun S; Zhou W; Li X; Peng F; Yan M; Zhan Y; An F; Li X; Liu Y; Liu Q; Piao H
Cancer Commun (Lond); 2021 Sep; 41(9):851-866. PubMed ID: 34251762
[TBL] [Abstract][Full Text] [Related]
9. PFDN2 promotes cell cycle progression via the hnRNPD-MYBL2 axis in gastric cancer.
He Q; Ding Z; Chen T; Wu H; Song J; Xiang Z; Yang C; Wang S; Xiong B
Front Oncol; 2023; 13():1164070. PubMed ID: 37538116
[TBL] [Abstract][Full Text] [Related]
10. Prefoldin 6 promotes glioma progression via the AKT signalling pathway.
Jiang L; Liu J
Cell Biol Int; 2023 Jan; 47(1):52-62. PubMed ID: 36300673
[TBL] [Abstract][Full Text] [Related]
11. Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
Schmid P; Cortes J; Dent R; Pusztai L; McArthur H; Kümmel S; Bergh J; Denkert C; Park YH; Hui R; Harbeck N; Takahashi M; Untch M; Fasching PA; Cardoso F; Andersen J; Patt D; Danso M; Ferreira M; Mouret-Reynier MA; Im SA; Ahn JH; Gion M; Baron-Hay S; Boileau JF; Ding Y; Tryfonidis K; Aktan G; Karantza V; O'Shaughnessy J;
N Engl J Med; 2022 Feb; 386(6):556-567. PubMed ID: 35139274
[TBL] [Abstract][Full Text] [Related]
12. The Role of the CREB Protein Family Members and the Related Transcription Factors in Radioresistance Mechanisms.
Stati G; Passaretta F; Gindraux F; Centurione L; Di Pietro R
Life (Basel); 2021 Dec; 11(12):. PubMed ID: 34947968
[TBL] [Abstract][Full Text] [Related]
13. Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects.
Dempster JM; Boyle I; Vazquez F; Root DE; Boehm JS; Hahn WC; Tsherniak A; McFarland JM
Genome Biol; 2021 Dec; 22(1):343. PubMed ID: 34930405
[TBL] [Abstract][Full Text] [Related]
14. Integrated cross-study datasets of genetic dependencies in cancer.
Pacini C; Dempster JM; Boyle I; Gonçalves E; Najgebauer H; Karakoc E; van der Meer D; Barthorpe A; Lightfoot H; Jaaks P; McFarland JM; Garnett MJ; Tsherniak A; Iorio F
Nat Commun; 2021 Mar; 12(1):1661. PubMed ID: 33712601
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of AURKA by miR-4715-3p in upper gastrointestinal cancers.
Gomaa A; Peng D; Chen Z; Soutto M; Abouelezz K; Corvalan A; El-Rifai W
Sci Rep; 2019 Nov; 9(1):16970. PubMed ID: 31740746
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
